Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac PET for Detection of Cardiac Sympathetic Dysinnervation to Guide Ablation of Ventricular Tachycardia
NCT02962076Phase 1Terminated
- Start
- Sep 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 11C-meta-hydroxyephedrine in ventricular tachycardia (VT). Primary endpoint: Correlation Between PET Data and Electroanatomic Data at 1 week. Started Sep 2020; status: terminated.
02
Drugs
11C-meta-hydroxyephedrine
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT02962076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962076.